Inventor · disambiguated record
Adrian D. Hobson
Also filed as: HOBSON ADRIAN · HOBSON ADRIAN D · HOBSON ADRIAN DONALD
22 granted patents·16 pending applications·144 citations·filing 2007–2023
94Inventor score
Top patents by PatentIndex Score
38 records- 0192US8648069B25-substituted indazoles as kinase inhibitorsAKRITOPOULOU-ZANZE IRINI·Filed 2008·Granted Feb 11, 2014·44 cites·7 claims
- 0290US8754107B2Aminopyrrolidines as chemokine receptor antagonistsGEORGE DAWN M·Filed 2007·Granted Jun 17, 2014·24 cites·17 claims
- 0390US7834039B2Oxadiazole compoundsABBOTT LAB·Filed 2007·Granted Nov 16, 2010·36 cites·13 claims
- 0489US10668167B2Glucocorticoid receptor agonist and immunoconjugates thereofABBVIE INC·Filed 2019·Granted Jun 2, 2020·5 cites·4 claims
- 0584US10807991B2Spiro-cyclic amine derivatives as S1P modulatorsABBVIE BV·Filed 2018·Granted Oct 20, 2020·2 cites·9 claims
- 0684US9163007B25-substituted indazoles as kinase inhibitorsABBVIE INC·Filed 2013·Granted Oct 20, 2015·8 cites·6 claims
- 0783US9951084B2Spiro-cyclic amine derivatives as S1P modulatorsABBVIE BV·Filed 2016·Granted Apr 24, 2018·4 cites·10 claims
- 0878US10772970B2Glucocorticoid receptor agonist and immunoconjugates thereofABBVIE INC·Filed 2018·Granted Sep 15, 2020·1 cites·6 claims
- 0977US8796262B2Fused heterocyclic derivatives as S1P modulatorsSMID PIETER·Filed 2011·Granted Aug 5, 2014·5 cites·31 claims
- 1077US8445686B24-(4-pyridinyl)-benzamides and their use as rock activity modulatorsMACK HELMUT·Filed 2008·Granted May 21, 2013·3 cites·21 claims
- 1176US12121589B2Anti-CD19 antibody drug conjugatesABBVIE BIOTHERAPEUTICS INC·Filed 2023·Granted Oct 22, 2024·0 cites·3 claims
- 1276US10179791B2Spiro-cyclic amine derivatives as S1P modulatorsSTOIT AXEL·Filed 2011·Granted Jan 15, 2019·3 cites·22 claims
- 1376US9670220B2Fused heterocyclic derivatives as S1P modulatorsABBVIE BV·Filed 2015·Granted Jun 6, 2017·2 cites·24 claims
- 1475US8895749B24-(4-pyridinyl)-benzamides and their use as rock activity modulatorsABBVIE DEUTSCHLAND·Filed 2013·Granted Nov 25, 2014·2 cites·11 claims
- 1573US9096612B2Fused heterocyclic derivatives as S1P modulatorsABBVIE BV·Filed 2013·Granted Aug 4, 2015·2 cites·22 claims
- 1669US10106501B2Nuclear receptor modulatorsABBVIE INC·Filed 2016·Granted Oct 23, 2018·1 cites·53 claims
- 1769US2023066771A1Nuclear receptor modulatorsABBVIE INC·Filed 2021·Application pending·0 cites
- 1868US11427598B2Spiro-cyclic amine derivatives as S1P modulatorsABBVIE DEUTSCHLAND·Filed 2020·Granted Aug 30, 2022·0 cites·10 claims
- 1967US2022354959A1Glucocorticoid receptor agonist and immunoconjugates thereofABBVIE INC·Filed 2021·Application pending·0 cites
- 2065US8217027B2Sphingosine-1-phosphate receptor agonist and antagonist compoundsWALLACE GRIER A·Filed 2008·Granted Jul 10, 2012·2 cites·18 claims
- 2165US2021130293A1Nuclear receptor modulatorsABBVIE INC·Filed 2019·Application pending·0 cites
- 2262US2020338208A1Glucocorticoid receptor agonist and immunoconjugates thereofABBVIE INC·Filed 2020·Application pending·0 cites
- 2361US2018126000A1Glucocorticoid receptor agonist and immunoconjugates thereofABBVIE INC·Filed 2017·Application pending·0 cites
- 2458US2015105386A14-(4-pyridinyl)-benzamides and their use as rock activity modulatorsABBVIE DEUTSCHLAND·Filed 2014·Application pending·0 cites
- 2556US2021015938A1Glucocorticoid receptor agonist and immunoconjugates thereofABBVIE INC·Filed 2020·Application pending·0 cites
- 2656US2019055196A1Nuclear receptor modulatorsABBVIE INC·Filed 2018·Application pending·0 cites
- 2752US2010035919A1Compounds useful as inhibitors of protein kinasesABBOTT LAB·Filed 2009·Application pending·0 cites
- 2850US2009069288A1Novel therapeutic compoundsBREINLINGER ERIC C·Filed 2008·Application pending·0 cites
- 2941US9115151B2Substituted 2,10-dihydro-9-oxa-1,2,4A-triazaphenanthren-3-ones and uses thereofGEORGE DAWN M·Filed 2014·Granted Aug 25, 2015·0 cites·19 claims
- 3041US2013072470A1Novel tricyclic compoundsWISHART NEIL·Filed 2012·Application pending·0 cites
- 3141US2022265842A1Anti-cd40 antibody drug conjugatesABBVIE INC·Filed 2018·Application pending·0 cites
- 3239USRE48301EFused heterocyclic derivatives as S1P modulatorsABBVIE BV·Filed 2011·Granted Nov 10, 2020·0 cites·39 claims
- 3337US2011152243A1Novel thienopyrrole compoundsABBOTT LAB·Filed 2010·Application pending·0 cites
- 3436US9045441B2(Thio)morpholine derivatives as S1P modulatorsIWEMA BAKKER WOUTER I·Filed 2010·Granted Jun 2, 2015·0 cites·20 claims
- 3535US2010216762A1Agonists and Antagonists of the S1P5 Receptor, and Methods of Use ThereofABBOTT LAB·Filed 2010·Application pending·0 cites
- 3634US2012238549A1Nuclear Hormone Receptor ModulatorsCUSACK KEVIN P·Filed 2012·Application pending·0 cites
- 3733US2011207704A1Novel Oxadiazole CompoundsABBOTT LAB·Filed 2010·Application pending·0 cites
- 3832US9273017B2(Thio)morpholine derivatives as S1P modulatorsABBVIE BAHAMAS LTD·Filed 2015·Granted Mar 1, 2016·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when Adrian D. Hobson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →